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MidazolamAbstract Background: Following strabismus surgery under sevoflurane anesthesia children often
experience emergence agitation (EA) and postoperative vomiting (POV). This study compared
the effects of premedication with intranasal dexmedetomidine, midazolam, and placebo on
postoperative EA and POV.
Methods: 105 children (aged 1–7 years) undergoing elective strabismus surgery under sevoflurane
anesthesia were randomly assigned to one of three groups (n= 35 each). Preoperatively,
group D received intranasal (IN) dexmedetomidine (1 lg/kg), group M received IN midazolam
(0.1 mg/kg), and group C received (1 ml) IN normal saline. Agitation scores (Pediatric Anesthesia
Emergence Delirium [PAED] scale) and POV were assessed in post-anesthesia care unit (PACU).
The incidence of intraoperative Oculocardiac Reflex OCR events, Time to spontaneous eye
opening, Postoperative pain score, total consumption of rescue analgesia and time to discharge
from PACU were also assessed.
Results: 98 children completed the study. Incidence of agitation (defined as PAED scoreP 10) was
significantly higher in the control group and the midazolam group than in the dexmedetomidine
group (P= 0.014), and the number of patients who developed severe agitation requiring fentanyl
(PAED scoreP 15) was also higher in the control group (P= 0.042).
There was no significant difference between the incidence of POV in the PACU between the control
group (28%) and the midazolam group (21%); however, the incidence was significantly lower in the
dexmedetomidine group (15%). The number of intraoperative OCR events was significantly higher
in the control group (39%) than in the dexmedetomidine (0%; P= 0.006) and in the midazolam
group the incidence was higher than the dexmedetomidine (9%; 3 events) but did not reach
statistical significance.
286 H.M.M. Abdelaziz et al.Conclusion: Administration of intranasal dexmedetomidine to children undergoing strabismus
surgery under sevoflurane anesthesia resulted in a reduced incidence of EA compared with intrana-
sal midazolam or placebo. The incidence of POV and intraoperative OCR was also significantly
lower with dexmedetomidine.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Emergence agitation (EA) is a complex behavioral disturbance
characterized by psychomotor agitation, perceptual distur-
bances, delusions, and disorientation during recovery from
general anesthesia [1]. The incidence of EA in children is higher
than in adults ranging from ten to eighty percent [2].
Agitated behavior associated with EA can delay discharge
from the post-anesthesia care unit (PACU), decrease parent
and caregiver satisfaction, and increase the overall cost to
the institution [3]. Risk factors for development of EA include
preschool age, previous surgery, ophthalmology or otorhino-
laryngology procedures, and inhalation agents associated with
fast emergence [4].
Strabismus surgery is one of the most common eye opera-
tions in children and it may be associated with significant post-
operative pain [5]. Pain can cause distress, anxiety and
agitation in children [6]. The oculocardiac reflex (OCR) is
another major complication of pediatric strabismus surgery
when the heart rate drops to 20% of the resting rate [7]. The
incidence of OCR during strabismus surgery has been vari-
ously reported between 14% and 90%, depending on premed-
ication and the anesthetic agent used [8,9]. Strabismus surgery
is also associated with significant postoperative vomiting
(POV) with an incidence of approximately 30% [10], and this
contributes significantly to the postoperative distress observed
in these children and subsequently limits the use of opioids for
pain management after strabismus surgery [11,12].
Sevoflurane is frequently used for pediatric anesthesia
because it has low pungency and rapid onset and offset of action
[13,14]. The reported incidence of emergence agitation (EA) fol-
lowing sevoflurane anesthesia varies from 10% to 80% between
studies, suggesting that EA may depend on numerous factors.
Midazolam is an anxiolytic, sedative, hypnotic, and amne-
sic drug and is used for premedication in children via several
routes [15–19]. Previous studies have shown that intranasal
administration of midazolam is easy, effective, and noninva-
sive, but may cause nasal irritation [20]. Other adverse effects
of midazolam include postoperative behavioral changes, cog-
nitive impairment, and respiratory depression [21].
Dexmedetomidine is a potent, highly selective, and specific
a2 adrenoreceptor agonist that has both sedative and analgesic
effects. Unlike traditional gabaminergic sedative drugs, the
primary site of action of dexmedetomidine is the locus coeru-
leus rather than the cerebral cortex [22]. Therefore, its induced
sedation is characterized by an easy and quick arousal from
sedation resembling natural sleep [23].
There is evidence that dexmedetomidine decreases the
incidence of EA after sevoflurane anesthesia in children
undergoing different surgical procedures [24]. It has also beenreported that dexmedetomidine can lower the incidence of
POV, and decrease the occurrence of OCR during strabismus
surgery [25].
The present study was undertaken to investigate the relative
benefits of using intranasal dexmedetomidine or midazolam
premedication in sevoflurane anesthetized children undergoing
strabismus surgery. The primary objective of this study was to
compare the effects of intranasal dexmedetomidine and intra-
nasal midazolam on the incidence of EA after sevoflurane
anesthesia in children undergoing strabismus surgery. We
hypothesized that the incidence of EA would be lower with
dexmedetomidine due to its sedative, anxiolytic, and analgesic
effects. The secondary objective was to estimate the effects of
the two drugs on POV and the incidence of OCR.
2. Methodology
The study was conducted in Magrabi specialist eye hospital
between September 2013 and April 2015. Approval by the
local Institutional Review Board (IRB), and parental written
informed consent were obtained. Children aged between 1
and 7 years of American Society of Anesthesiologists (ASA)
physical status I or II undergoing strabismus surgeries were
included in this double blind, prospective, randomized study.
Primary exclusion criteria included ASA III and IV children,
children with developmental delays, any neurological disease
associated with symptoms of agitation. Secondary exclusion
criteria included parental refusal of consent and allergy to
any of the study medications. Of 123 children screened, 105
patients were found eligible and enrolled in the study.
All children were fasted from solid foods for 6 h before the
procedure; clear liquids were permitted until 2 h prior to
admission to the OR. Before entrance to the OR, Patients were
allocated randomly to one of three groups using computer-
generated random numbers which were obtained and kept in
opaque sealed envelopes that were opened by an independent
anesthesiologist not involved in the study: group D, included
patients who received intranasal (IN) dexmedetomidine
(1 lg/kg), group M included patients who received IN midazo-
lam (0.1 mg/kg), and group C included patients who received
IN normal saline. All study drugs were prepared by an anes-
thesiologist who was blinded to the details of the study.
Parental presence was facilitated during induction of anes-
thesia. An observer blinded to the group evaluated the modi-
fied Yale Preoperative Anxiety Scale (m-YPAS) [26] in the
preoperative holding area. Routine monitoring of electrocar-
diography (ECG), noninvasive blood pressure (NIBP), and
Oxygen Saturation (SpO2), were attached before induction
of anesthesia and continued during surgery. Anesthesia was
induced with 8% sevoflurane in 50% nitrous oxide, and
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inserted for maintenance of airway. After the fixation of the
laryngeal mask airway, anesthesia was maintained with 50%
nitrous oxide in oxygen and sevoflurane with spontaneous
breathing. All children received 15 mg/kg intravenous acetami-
nophen for analgesia. All patients received topical anesthesia
with two conjunctival drops of 0.4% oxybuprocaine on four
occasions: before washing the eye at the beginning of the oper-
ation, before incision of the conjunctiva, before closure, and
after closure of the conjunctiva.
The minimal heart rate during this procedure was recorded
during traction of extraocular muscles. Oculocardiac reflex
(OCR) was defined as an acute reduction in heart rate of
P20% associated with traction on an eye muscle. Atropine
(0.01 mg/kg IV) was given in cases where the heart rate did
not return to baseline after release of the extraocular muscle
or if the reflex recurred. The number of OCR events was
recorded. After the end of surgery, at the time of dressing, chil-
dren were administered 100% oxygen and the laryngeal mask
airway was removed. Sevoflurane was turned off after laryn-
geal mask airway removal.
The independent investigator blinded to the study continu-
ously monitored the patient in the PACU and recorded the
maximum value of each variable of the Pediatric Anesthesia
Emergence Delirium (PAED) scale [27] at arrival, 5 min later
then every 15 min for the first hour starting from time of awak-
ening. Patients who were asleep during these intervals were
given zero score in PAED scale.
Postoperative pain was assessed by using face, legs, activity,
cry and consolability (FLACC) pain scale [28,29] in all patients
every 15 min for 1 h.
Blinded study personnel recorded the number of episodes of
vomiting or retching occurring in the PACU. For the purpose
of the current study, vomiting was defined as the forceful oral
expulsion of liquid or solid gastric contents. Both vomiting
and retching were considered as vomiting events. Patients
requesting an antiemetic were treated with ondansetron
0.1 mg/kg1. If the vomiting remained uncontrolled, repeat
administrations of ondansetron were given up to a maximum
total dose of 4 mg. The total consumption of antiemetic was
recorded.
The need for rescue analgesia in the form of IV acetamino-
phen was noted in the PACU. Time to spontaneous eye open-
ing and time to discharge from PACU were also noted.
Children were discharged when they were calm, had no pain
and had a modified Aldrete [30] score >9.
The PAED scale contains five items (eye contact, purpose-
fulness of actions, awareness of surroundings, restlessness and
consolability), each scored on a 0 to 4 scale, for a maximum of
20 points. A perfectly calm child scores 0 and extreme agita-
tion corresponds to 20 points. The peak EA score was
recorded. Agitation scores <10 were interpreted as an absence
of agitation, scores P10 were regarded as presence of agita-
tion, and scores P15 were regarded as severe agitation.
For patients with a total PAED score of >10 or a FLACC
scale >4 in the PACU, the first measure was to facilitate
parental contact and when this failed intravenous fentanyl
0.5 lg/kg was administered as rescue medication and repeated
after 10 min if the agitation did not subside. Patients who
received intravenous fentanyl were removed from the analysis
after the administration of fentanyl.2.1. Sample size calculation
We performed a pilot study of 10 patients and analyzed the
results by power calculation to determine the number of
patients required in each group. We wished to detect a mini-
mum clinically important difference of 30% decrease in the
primary end point (PAED score) between the three groups.
The sample size was calculated based on the assumptions of
standard deviation of PAED score values of up to 4, with a
of 0.05 (two tailed) and type II error of 0.2. Therefore, 30
patients were required in each group and we decided to include
35 patients per group to compensate any possible dropouts.
The primary outcome measured was the PAED scale at differ-
ent time intervals in each group. The secondary outcomes mea-
sured were the incidence of emergence delirium, intraoperative
OCR events, and postoperative vomiting.
2.2. Statistical analysis
Data were statistically described in terms of median and range,
mean ± standard deviation (±SD), frequencies and percent-
ages when appropriate. Comparison of quantitative variables
between the study groups was done using one way ANOVA
for independent samples in comparing three groups when nor-
mally distributed and Kruskal Wallis for independent samples
when not normally distributed. For comparing categorical
data, Chi square test was performed. A probability value (p
value) less than 0.05 was considered statistically significant.
All statistical calculations were done using computer programs
Microsoft Excel 2010 (Microsoft Corporation, NY, USA) and
SPSS (Statistical Package for the Social Science; SPSS Inc.,
Chicago, IL, USA) version 15 for Microsoft Windows.
3. Results
105 subjects were initially enrolled in the study. 7 subjects were
subsequently excluded from the analysis, of these, 6 were
excluded because they received fentanyl (3 in the control
group, two in the midazolam group, and one in the
dexmedetomidine group), and one subject in the dexmedeto-
midine group was lost to follow-up. 98 subjects completed
the study. The subjects in the three groups were comparable
with respect to age, body weight, sex, m-YPAS scale, duration
of surgery, and mean time to eye opening (Table 1). The dura-
tion of stay in the PACU and the number of patients requiring
rescue analgesia were also comparable in the three study
groups. There were no significant between-group differences
in the pain scores, measured as maximal FLACC scores in
the PACU (Table 1).
The incidence of agitation (defined as PAED scoreP 10)
was significantly higher in the control group and the midazo-
lam group than in the dexmedetomidine group (P= 0.014),
and the number of patients who developed severe agitation
requiring fentanyl (PAED scoreP 15) was also higher in the
control group than in the dexmedetomidine group
(P= 0.042). The incidence of severe agitation was significantly
higher in the control group than the midazolam group
(P= 0.017); however, there was no statistically significant dif-
ference between the dexmedetomidine group and the midazo-
lam group in this regard (Table 2).
Table 1 Demographic data, Preoperative Anxiety Scale, surgery duration, time to eye opening, pain scale, duration of stay in PACU,







ASA Status (I/II) 31/1 32/1 33/0
Age (year) 2.78 ± 1.67 2.68 ± 1.54 2.48 ± 1.17
Weight (kg) 11.4 ± 3.3 12 ± 3.9 11.8 ± 3.7
Gender (male/female) 18/14 17/16 17/16
Surgery duration (min) 42.27 ± 3.507 45.93 ± 3.378 46.27 ± 3.608
Time to eye opening (min) 3.23 ± 1.270 2.14 ± 0 .170 3.23 ± 1.270
Patients requiring rescue analgesia n (%) 6 (18%) 3(9%) 4(12%)
FLACC scale 3 (0–9) 3.5 (0–9) 3 (0–9)
m-YPAS scale 36 (24–61) 34 (25–61) 35 (26–58)
Duration of PACU stay (min) 43.68 ± 2.032 44.39 ± 3.432 45.78 ± 3.032
PACU, Post-anesthesia care unit; FLACC scale, Face, Legs, Activity, Cry and Consolability Scale; m-YPAS, modified Yale Preoperative
Anxiety Scale in the preoperative holding area. Values are expressed as mean ± SD or median (range).
Table 2 Incidence of emergence agitation (PAEDP 10), severe emergence agitation (PAEDP 15), postoperative vomiting (POV),







PAED scoreP 10, n (%) 15 (47%) 4 (12%)*,y 7 (21%)*
PAED scoreP 15, n (%) 8 (25%) 2 (6%)* 3 (9%)*
POV (one episode), n (%) 9 (28%) 5 (15%)*,y 7 (21%)
POV (two or more episodes), n (%) 7 (22%) 1 (3%)*,y 6 (18%)
Oculocardiac reflex requiring atropine, n (%) 13 (39%) 0 (0%)* 3 (9%)*
Nasal irritation, n (%) 0 (0%) 0 (0%)y 7 (21%)
PAED= Pediatric Anesthesia Emergence Delirium scale (scale 0–20); POV= postoperative vomiting.
* P< 0.05 for dexmedetomidine or midazolam group versus control group.
y P< 0.05 for dexmedetomidine versus midazolam group.
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incidence of POV occurring in the PACU between the control
group (28%) and the midazolam group (21%); however, the
incidence was significantly lower in the dexmedetomidine
group (15%) than both the control and the midazolam group.
Severe vomiting (two or more episodes, requiring administra-
tion of antiemetic medication) was observed in 7 subjects in
the control group, 6 subjects in the midazolam group, and 1
subject in the dexmedetomidine group, and the difference
was statistically significant between the dexmedetomidine
group and both the control and the midazolam groups
(Table 2).
The number of intraoperative OCR events was significantly
higher in the control group (13; 39%) than the dexmedeto-
midine (0%; P= 0.006) and the midazolam group. In the
midazolam group the incidence was higher (9%; 3 events) than
the dexmedetomidine group; however, the difference did not
reach statistical significance. Thirteen subjects in the control
group and three subjects in the midazolam group required
atropine for persistent bradycardia (Table 2).
The PAED scale scores were significantly lower in the
dexmedetomidine and midazolam groups than in the control
group. There was also a statistically significant difference in
PAED scale scores between the dexmedetomidine group and
midazolam group in favor of the dexmedetomidine group.
These differences were evident at admission to the PACU,
5 min, 15 min, and 30 min later. There were, however, nodifferences between the 3 groups at 45 min and 60 min from
admission to the PACU (Table 3).4. Discussion
The results of this study showed that IN dexmedetomidine
premedication for children undergoing strabismus surgery
under sevoflurane anesthesia reduces the incidence of emer-
gence delirium when compared with intranasal midazolam or
placebo. The study also showed that the incidence of OCR
occurring intraoperatively and the incidence of postoperative
vomiting were also lower in children receiving intranasal
dexmedetomidine premedication.
Strabismus surgery is performed commonly in children to
restore binocular vision as well as for cosmetic reasons. Unde-
sired effects, including EA [31], POV [32], and postoperative
pain [33] are major causes of distress after recovery from gen-
eral anesthesia.
In the current study the intranasal route for drug adminis-
tration was chosen as a relatively quick, simple method show-
ing benefits over other routes which require more patient
cooperation. The Intranasal administration of midazolam
has previously been shown to be an effective premedication
agent for children. However, the sensation of burning and
nasal irritation can be considered as disadvantages of this
route [34,35]. In this study 7 out of 33 children showed signs
Table 3 Pediatric Anesthesia Emergence Delirium (PAED)
scale in control, dexmedetomidine, and midazolam groups at







Arrival – Median (range) 9 (0–18) 4 (0–16)*,y 7 (0–16)*
5 min – Median (range) 9 (0–15) 4 (0–15)*,y 6 (0–15)*
15 min – Median (range) 7 (0–15) 4 (0–9)*,y 6 (0–10)*
30 min – Median (range) 5 (0–17) 0 (0–5)*,y 3 (0–15)*
45 min – Median (range) 2 (0–17) 0 (0–5) 2 (0–15)
60 min – Median (range) 2 (0–17) 0 (0) 0 (0–2)
PAED scale at arrival to PACU, and 5, 15, 30, 45 and 60 min later.
Data are expressed as median and range. Between-group analysis
using one way ANOVA.
* P> 0.05 for dexmedetomidine or midazolam group vs. control
group.
y P> 0.05 for dexmedetomidine vs. midazolam group.
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On the other hand, this sign was not seen in any of the children
when intranasal dexmedetomidine was used. Similar observa-
tions were previously reported by Yuen et al. In their study,
the authors showed that 1 lg/kg intranasal dexmedetomidine
was an effective technique for producing sedation in children
and it caused no discomfort during administration [36].
Emergence agitation is a common side effect of sevoflurane
in pediatric anesthesia, yet there is no clinical evidence that
agitation affects long term outcome. As the mechanism of
agitation after sevoflurane anesthesia is not clear, there is no
well-known prophylaxis or treatment, although the incidence
of this excitatory behavior seems to be reduced by the
perioperative use of sedative and analgesic drugs [37].
In the current study, the PAED scale scores were signifi-
cantly lower in the dexmedetomidine and midazolam groups
than in the control group and there was also a statistically sig-
nificant difference between the dexmedetomidine group and
midazolam group in favor of the dexmedetomidine group.
Furthermore, the incidence of emergence delirium and severe
emergence delirium was also significantly lower in the
dexmedetomidine group compared to both the midazolam
and the control groups. No previous studies were done to com-
pare the effect of the nasal administration of these drugs on the
incidence of emergence delirium following recovery from pedi-
atric strabismus surgery; however, other studies obtained com-
parable results in different types of pediatric surgery and using
different routes. Sun et al. conducted a meta-analysis of ran-
domized controlled trials to compare dexmedetomidine with
midazolam as premedication in children undergoing different
types of surgery. Their pooled data analysis revealed that
dexmedetomidine premedication effectively lowered the
incidence of agitation or delirium following the operations
(RR: 0.59; 95% CI: 0.40, 0.88; I2 = 25%; NNT: 8.4). The
authors concluded that dexmedetomidine premedication was
superior to midazolam premedication in terms of reducing
emergence agitation or delirium [38].
Sheta et al. compared premedication with intranasal mida-
zolam or intranasal dexmedetomidine in children undergoing
complete dental rehab and found a significantly lower
incidence of postoperative agitation (agitation score of 3, 4)in the dexmedetomidine group compared to midazolam group
(11.1% vs. 30.6%, respectively, CI 0.01–0.37, P= 0.036) [39].
Ming et al. compared two different doses of dexmedeto-
midine and placebo in children undergoing adenotonsilectomy
under sevoflurane anesthesia and obtained significantly lower
agitation scores in both groups receiving dexmedetomidine
[40].
On the other hand, Asaad et al. compared the effectiveness
of fentanyl and dexmedetomidine administered by the intra-
venous route in decreasing emergence agitation in children
undergoing different surgeries under general anesthesia and
caudal block. They found a significant difference when com-
paring the two groups to placebo but no significant difference
was found when comparing fentanyl and dexmedetomidine
[41]. The discrepancy between these results and our own may
be due to the different types of surgery and anesthetic tech-
niques used which may have been provided for confounding
variables. Similarly, Akin et al. compared intranasal
dexmedetomidine and intranasal midazolam in children under-
going adenotonsilectomy under sevoflurane anesthesia and
found comparable incidences of emergence delirium in both
study groups [42].
Our secondary endpoints were the incidence of POV and
the incidence of OCR. Strabismus surgery is often associated
with a remarkable high rate of PONV [43]. The reasons for
the fairly high rates of PONV are not, as yet, understood.
Van den Berg et al. suggested in a previous study that an
‘‘oculo-emetic reflex”may be responsible for the high incidence
of PONV following strabismus surgery [44]. Intraoperative
recession and manipulation cause traction on eye muscle spin-
dles; thus, via vagal and trigeminal afferents may activate the
vomiting system. Another hypothesis is based on an optoki-
netic imbalance and disturbance of visual axes [45]. Recent
analyses have demonstrated convincingly, that in the pediatric
population strabismus surgery is clearly a risk factor that
needs to be taken into account when the risk for POV should
be assessed in children [46].
Our study found a favorable effect of dexmedetomidine on
the incidence of POV. The incidence of POV was significantly
lower with dexmedetomidine than with midazolam, or
placebo. The antiemetic effect of dexmedetomidine may be
explained by the alpha 2 adrenoceptor agonist effect of
dexmedetomidine which, similar to clonidine, decreases the
noradrenergic activity as a result of binding to the alpha 2
presynaptic inhibitory receptors in the locus coeruleus an inhi-
bition that probably results in an antiemetic effect [47].
In other studies, dexmedetomidine has been shown to be
effective in the treatment of cyclical vomiting [48,49]. It has
also been shown to reduce the requirement for postoperative
opioids, and thereby lower the risk of opioid-induced nausea
and vomiting [50,51]. These antiemetic properties of
dexmedetomidine further support its use as an adjunct for gen-
eral anesthesia in children.
Our results are consistent with the results obtained by Suga
et al. who compared the effect of 2 different doses of
dexmedetomidine or placebo on the incidence of postoperative
nausea and vomiting in 97 children undergoing ear reconstruc-
tive surgery. The authors found that the intraoperative infu-
sion of dexmedetomidine had an opioid sparing effect and
reduced incidence of PONV in a ‘‘dose-dependent” manner
[52].
290 H.M.M. Abdelaziz et al.Again similar results were obtained by Chen et al. who
compared the incidence of POV in children undergoing strabis-
mus surgery under sevoflurane anesthesia. The patients were
assigned to intraoperatively receive placebo, dexmedeto-
midine, or ketamine. The authors found that the incidence of
POV was similar with ketamine and placebo, but less with
dexmedetomidine [25].
OCR is another complication that often occurs during stra-
bismus surgery. It is defined as a fall of heart rate of more than
20% and is caused by traction on the extraocular muscles. In
the current study there were no significant differences in the
incidence of oculocardiac reflex between the dexmedetomidine
and the midazolam groups; however, the incidence of OCR was
significantly higher in the control group. Similar results were
obtained by Mizrak et al. who found a significant reduction
in the incidence of OCR in children undergoing strabismus sur-
gery under ketamine anesthesia when dexmedetomidine was
added as premedication [53]. On the other hand, conflicting
results were obtained by Kim et al. [54] who found no difference
in the incidence of OCR events when comparing low-dose infu-
sion of dexmedetomidine or placebo in children undergoing
strabismus surgery. This may be due to the fact that, in their
study, Kim et al. administered fentanyl (1 lg/kg IV) to all chil-
dren after induction of anesthesia.
In conclusion, the administration of intranasal dexmedeto-
midine to children undergoing strabismus surgery under
sevoflurane anesthesia resulted in a reduced incidence of EA
compared with midazolam or placebo. The incidence of POV
was significantly lower with dexmedetomidine than with mida-
zolam or placebo. These findings suggest that intranasal
dexmedetomidine with sevoflurane may form an effective com-
bination for anesthesia in children undergoing strabismus
surgery.
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